Impact of a bronchiolitis clinical care pathway on treatment and hospital stay

Claire Walker, Susan Danby, Steve Turner

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

UNLABELLED: Bronchiolitis is a common lower respiratory tract infection of infancy where management has varied considerably in the past. The aim of the present study was to determine whether patient treatment and outcomes changed after introduction of a clinical care pathway. Infants aged up to 6 months admitted to hospital with bronchiolitis were identified as part of an annual audit of bronchiolitis management between winters 2003/2004 and 2009/2010. The primary outcome, duration of stay (DOS), was compared before and after the clinical pathway was introduced before the winter 2005/2006. There were 328 infants identified, mean age 75 days, respiratory syncitial virus was detected in 89%. After the clinical pathway was introduced, the proportion of infants prescribed salbutamol fell from 50% to 8% (p < 0.001) and ipratropium bromide from 38% to 0% (p < 0.001) but the proportion prescribed antibiotics was unchanged. The median DOS was 79 h prior to the clinical pathway and 66 h afterwards (p = 0.010) but there was no difference in days where supplemental oxygen or nasogastric feeding was required.

CONCLUSIONS: A clinical pathway for the management of acute bronchiolitis can be implemented in the hospital setting and the conservative approach, in particular not prescribing bronchodilators, is not associated with prolonged duration of stay.

Original languageEnglish
Pages (from-to)827-832
Number of pages6
JournalEuropean Journal of Pediatrics
Volume171
Issue number5
Early online date23 Dec 2011
DOIs
Publication statusPublished - May 2012

Fingerprint

Bronchiolitis
Critical Pathways
Length of Stay
Management Audit
Ipratropium
Therapeutics
Albuterol
Bronchodilator Agents
Respiratory Tract Infections
Oxygen
Anti-Bacterial Agents
Viruses

Keywords

  • bronchiolitis
  • bronchodilator agents
  • critical pathways
  • disease management
  • female
  • hospitalization
  • humans
  • infant
  • infant, newborn
  • length of stay
  • male
  • retrospective studies
  • treatment outcome

Cite this

Impact of a bronchiolitis clinical care pathway on treatment and hospital stay. / Walker, Claire; Danby, Susan; Turner, Steve.

In: European Journal of Pediatrics, Vol. 171, No. 5, 05.2012, p. 827-832.

Research output: Contribution to journalArticle

@article{1c83f0c868f34e1fa2491c8251ae0611,
title = "Impact of a bronchiolitis clinical care pathway on treatment and hospital stay",
abstract = "UNLABELLED: Bronchiolitis is a common lower respiratory tract infection of infancy where management has varied considerably in the past. The aim of the present study was to determine whether patient treatment and outcomes changed after introduction of a clinical care pathway. Infants aged up to 6 months admitted to hospital with bronchiolitis were identified as part of an annual audit of bronchiolitis management between winters 2003/2004 and 2009/2010. The primary outcome, duration of stay (DOS), was compared before and after the clinical pathway was introduced before the winter 2005/2006. There were 328 infants identified, mean age 75 days, respiratory syncitial virus was detected in 89{\%}. After the clinical pathway was introduced, the proportion of infants prescribed salbutamol fell from 50{\%} to 8{\%} (p < 0.001) and ipratropium bromide from 38{\%} to 0{\%} (p < 0.001) but the proportion prescribed antibiotics was unchanged. The median DOS was 79 h prior to the clinical pathway and 66 h afterwards (p = 0.010) but there was no difference in days where supplemental oxygen or nasogastric feeding was required.CONCLUSIONS: A clinical pathway for the management of acute bronchiolitis can be implemented in the hospital setting and the conservative approach, in particular not prescribing bronchodilators, is not associated with prolonged duration of stay.",
keywords = "bronchiolitis, bronchodilator agents, critical pathways, disease management, female, hospitalization, humans, infant, infant, newborn, length of stay, male, retrospective studies, treatment outcome",
author = "Claire Walker and Susan Danby and Steve Turner",
year = "2012",
month = "5",
doi = "10.1007/s00431-011-1653-9",
language = "English",
volume = "171",
pages = "827--832",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Impact of a bronchiolitis clinical care pathway on treatment and hospital stay

AU - Walker, Claire

AU - Danby, Susan

AU - Turner, Steve

PY - 2012/5

Y1 - 2012/5

N2 - UNLABELLED: Bronchiolitis is a common lower respiratory tract infection of infancy where management has varied considerably in the past. The aim of the present study was to determine whether patient treatment and outcomes changed after introduction of a clinical care pathway. Infants aged up to 6 months admitted to hospital with bronchiolitis were identified as part of an annual audit of bronchiolitis management between winters 2003/2004 and 2009/2010. The primary outcome, duration of stay (DOS), was compared before and after the clinical pathway was introduced before the winter 2005/2006. There were 328 infants identified, mean age 75 days, respiratory syncitial virus was detected in 89%. After the clinical pathway was introduced, the proportion of infants prescribed salbutamol fell from 50% to 8% (p < 0.001) and ipratropium bromide from 38% to 0% (p < 0.001) but the proportion prescribed antibiotics was unchanged. The median DOS was 79 h prior to the clinical pathway and 66 h afterwards (p = 0.010) but there was no difference in days where supplemental oxygen or nasogastric feeding was required.CONCLUSIONS: A clinical pathway for the management of acute bronchiolitis can be implemented in the hospital setting and the conservative approach, in particular not prescribing bronchodilators, is not associated with prolonged duration of stay.

AB - UNLABELLED: Bronchiolitis is a common lower respiratory tract infection of infancy where management has varied considerably in the past. The aim of the present study was to determine whether patient treatment and outcomes changed after introduction of a clinical care pathway. Infants aged up to 6 months admitted to hospital with bronchiolitis were identified as part of an annual audit of bronchiolitis management between winters 2003/2004 and 2009/2010. The primary outcome, duration of stay (DOS), was compared before and after the clinical pathway was introduced before the winter 2005/2006. There were 328 infants identified, mean age 75 days, respiratory syncitial virus was detected in 89%. After the clinical pathway was introduced, the proportion of infants prescribed salbutamol fell from 50% to 8% (p < 0.001) and ipratropium bromide from 38% to 0% (p < 0.001) but the proportion prescribed antibiotics was unchanged. The median DOS was 79 h prior to the clinical pathway and 66 h afterwards (p = 0.010) but there was no difference in days where supplemental oxygen or nasogastric feeding was required.CONCLUSIONS: A clinical pathway for the management of acute bronchiolitis can be implemented in the hospital setting and the conservative approach, in particular not prescribing bronchodilators, is not associated with prolonged duration of stay.

KW - bronchiolitis

KW - bronchodilator agents

KW - critical pathways

KW - disease management

KW - female

KW - hospitalization

KW - humans

KW - infant

KW - infant, newborn

KW - length of stay

KW - male

KW - retrospective studies

KW - treatment outcome

U2 - 10.1007/s00431-011-1653-9

DO - 10.1007/s00431-011-1653-9

M3 - Article

C2 - 22193364

VL - 171

SP - 827

EP - 832

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 5

ER -